These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35588115)

  • 1. Markers of endothelial cell activation are associated with the severity of pulmonary disease in COVID-19.
    Osburn WO; Smith K; Yanek L; Amat-Alcaron N; Thiemann DR; Cox AL; Leucker TM; Lowenstein CJ
    PLoS One; 2022; 17(5):e0268296. PubMed ID: 35588115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes.
    Grobler C; Maphumulo SC; Grobbelaar LM; Bredenkamp JC; Laubscher GJ; Lourens PJ; Steenkamp J; Kell DB; Pretorius E
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID-19): evidence of acute and sustained endothelial cell activation.
    Ward SE; Curley GF; Lavin M; Fogarty H; Karampini E; McEvoy NL; Clarke J; Boylan M; Alalqam R; Worrall AP; Kelly C; de Barra E; Glavey S; Ni Cheallaigh C; Bergin C; Martin-Loeches I; Townsend L; Mallon PW; O'Sullivan JM; O'Donnell JS;
    Br J Haematol; 2021 Feb; 192(4):714-719. PubMed ID: 33326604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory and Prothrombotic Biomarkers Associated With the Severity of COVID-19 Infection.
    Lopez-Castaneda S; García-Larragoiti N; Cano-Mendez A; Blancas-Ayala K; Damian-Vázquez G; Perez-Medina AI; Chora-Hernández LD; Arean-Martínez C; Viveros-Sandoval ME
    Clin Appl Thromb Hemost; 2021; 27():1076029621999099. PubMed ID: 33835872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.
    Smadja DM; Mentzer SJ; Fontenay M; Laffan MA; Ackermann M; Helms J; Jonigk D; Chocron R; Pier GB; Gendron N; Pons S; Diehl JL; Margadant C; Guerin C; Huijbers EJM; Philippe A; Chapuis N; Nowak-Sliwinska P; Karagiannidis C; Sanchez O; Kümpers P; Skurnik D; Randi AM; Griffioen AW
    Angiogenesis; 2021 Nov; 24(4):755-788. PubMed ID: 34184164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction.
    Jezovnik MK; Poredos P
    Int Angiol; 2010 Jun; 29(3):226-31. PubMed ID: 20502419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible role of circulating endothelial cells in patients after acute myocardial infarction.
    Rakic M; Persic V; Kehler T; Bastiancic AL; Rosovic I; Laskarin G; Sotosek Tokmadzic V
    Med Hypotheses; 2018 Aug; 117():42-46. PubMed ID: 30077195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Spike Proteins and Cell-Cell Communication Induce P-Selectin and Markers of Endothelial Injury, NETosis, and Inflammation in Human Lung Microvascular Endothelial Cells and Neutrophils: Implications for the Pathogenesis of COVID-19 Coagulopathy.
    Bhargavan B; Kanmogne GD
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Endothelial Related Circulating Biomarkers in COVID-19. A Systematic Review and Meta-analysis.
    Lampsas S; Tsaplaris P; Pantelidis P; Oikonomou E; Marinos G; Charalambous G; Souvaliotis N; Mystakidi VC; Goliopoulou A; Katsianos E; Siasos G; Vavuranakis MA; Tsioufis C; Vavuranakis M; Tousoulis D
    Curr Med Chem; 2022; 29(21):3790-3805. PubMed ID: 34702152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone may improve severe COVID-19 via ameliorating endothelial injury and inflammation: A preliminary pilot study.
    Kim WY; Kweon OJ; Cha MJ; Baek MS; Choi SH
    PLoS One; 2021; 16(7):e0254167. PubMed ID: 34214123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study.
    Chong AY; Freestone B; Lim HS; Kistorp C; Gustafsson F; Hildebrandt P; Lip GY
    Int J Cardiol; 2007 Jun; 119(1):80-2. PubMed ID: 17027106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Von Willebrand factor and ADAMTS13 activity as clinical severity markers in patients with COVID-19.
    Marco A; Marco P
    J Thromb Thrombolysis; 2021 Aug; 52(2):497-503. PubMed ID: 33866481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Von Willebrand Factor in the Pathogenesis of Pulmonary Vascular Thrombosis in COVID-19.
    Babkina AS; Ostrova IV; Yadgarov MY; Kuzovlev AN; Grechko AV; Volkov AV; Golubev AM
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactive oxygen species in endothelial signaling in COVID-19: Protective role of the novel peptide PIP-2.
    Paul O; Akolia IK; Qin Tao J; Jain N; Louneva N; Montone KT; Fisher AB; Rajapakse CS; Bermudez C; Chatterjee S
    PLoS One; 2024; 19(5):e0289854. PubMed ID: 38771750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial Cell-Derived von Willebrand Factor Is the Major Determinant That Mediates von Willebrand Factor-Dependent Acute Ischemic Stroke by Promoting Postischemic Thrombo-Inflammation.
    Dhanesha N; Prakash P; Doddapattar P; Khanna I; Pollpeter MJ; Nayak MK; Staber JM; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1829-37. PubMed ID: 27444201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation.
    Conway DS; Pearce LA; Chin BS; Hart RG; Lip GY
    Circulation; 2003 Jul; 107(25):3141-5. PubMed ID: 12796127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a 'real-world' community cohort of patients with atrial fibrillation.
    Krishnamoorthy S; Khoo CW; Lim HS; Lane DA; Pignatelli P; Basili S; Violi F; Lip GY
    Eur J Clin Invest; 2013 Oct; 43(10):1032-8. PubMed ID: 23961715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial dysfunction contributes to COVID-19-associated vascular inflammation and coagulopathy.
    Zhang J; Tecson KM; McCullough PA
    Rev Cardiovasc Med; 2020 Sep; 21(3):315-319. PubMed ID: 33070537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of von Willebrand Factor in COVID-19 Associated Coagulopathy.
    Mei ZW; van Wijk XMR; Pham HP; Marin MJ
    J Appl Lab Med; 2021 Sep; 6(5):1305-1315. PubMed ID: 33930144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial injury in COVID-19 and septic patients.
    Hokama LT; Veiga ADM; Menezes MCS; Sardinha Pinto AA; de Lima TM; Ariga SKK; Barbeiro HV; Barbeiro DF; de Lucena Moreira C; Stanzani G; Brandao RA; Marchini JF; Alencar JC; Marino LO; Gomez LM; ; Souza HP
    Microvasc Res; 2022 Mar; 140():104303. PubMed ID: 34914941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.